Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Sell
32
SLP Quote, Financials, Valuation and Earnings
Last price:
$25.56
Seasonality move
:
2.37%
Day range:
$24.00 - $25.97
52-week range:
$24.00 - $51.22
Dividend yield:
0.94%
P/E ratio:
63.89x
P/S ratio:
6.97x
P/B ratio:
2.78x
Volume:
418.7K
Avg. volume:
171.5K
1-year change:
-42.88%
Market cap:
$513.5M
Revenue:
$70M
EPS (TTM):
$0.40
Analysts' Opinion
-
Consensus RatingSimulations Plus has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $49.40, Simulations Plus has an estimated upside of 93.31% from its current price of $25.56.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $37.00 representing 100% downside risk from its current price of $25.56.
Fair Value
-
According to the consensus of 7 analysts, Simulations Plus has 93.31% upside to fair value with a price target of $49.40 per share.
SLP vs. S&P 500
-
Over the past 5 trading days, Simulations Plus has underperformed the S&P 500 by -2.51% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Simulations Plus does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Simulations Plus has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Simulations Plus reported revenues of $18.9M.
Earnings Growth
-
Simulations Plus earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Simulations Plus reported earnings per share of $0.01.
Enterprise value:
495.3M
EV / Invested capital:
--
Price / LTM sales:
6.97x
EV / EBIT:
93.50x
EV / Revenue:
6.65x
PEG ratio (5yr expected):
14.57x
EV / Free cash flow:
63.74x
Price / Operating cash flow:
66.80x
Enterprise value / EBITDA:
40.81x
Gross Profit (TTM):
$43.5M
Return On Assets:
4.25%
Net Income Margin (TTM):
11.04%
Return On Equity:
4.58%
Return On Invested Capital:
4.58%
Operating Margin:
0.67%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2023-11-30 | 2024-11-30 | |
| Income Statement | ||||||
| Revenue | $53.5M | $62.1M | $74.4M | $14.5M | $18.9M | |
| Gross Profit | $42.7M | $48.5M | $43.5M | $9.8M | $10.2M | |
| Operating Income | $12M | $8.8M | $5.3M | $960K | $126K | |
| EBITDA | $15.7M | $12.8M | $12.1M | $2.1M | $2.4M | |
| Diluted EPS | $0.51 | $0.53 | $0.40 | $0.10 | $0.01 | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $131.2M | $139.9M | $148.7M | $129.7M | $40.4M | |
| Total Assets | $170.5M | $181M | $190.5M | $185.8M | $196.9M | |
| Current Liabilities | $5.5M | $9.6M | $8M | $8.6M | $9.7M | |
| Total Liabilities | $12.4M | $12.5M | $10.3M | $13.4M | $12.2M | |
| Total Equity | $158M | $168.5M | $180.1M | $172.3M | $184.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2023-11-30 | 2024-11-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $19M | $17.3M | $11.9M | $162K | -$1.3M | |
| Cash From Investing | -$4.1M | -$3.1M | -$40.2M | -$16.9M | -$3.1M | |
| Cash From Financing | -$7.2M | -$23.8M | -$5.2M | -$1M | $288K | |
| Free Cash Flow | $15.4M | $13M | $7.8M | -$936K | -$2.2M | |
SLP
Sector
Market Cap
$513.5M
$39.2M
Price % of 52-Week High
49.89%
45.93%
Dividend Yield
0.94%
0%
Shareholder Yield
--
-0.81%
1-Year Price Total Return
-42.88%
-38.63%
Beta (5-Year)
0.894
0.774
Dividend yield:
0.94%
Annualized payout:
$0.24
Payout ratio:
43.82%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$25.76
200-day SMA
Sell
Level
$34.43
Bollinger Bands (100)
Sell
Level
27.62 - 33.46
Chaikin Money Flow
Buy
Level
13.9M
20-day SMA
Sell
Level
$27.90
Relative Strength Index (RSI14)
Sell
Level
32.76
ADX Line
Sell
Level
44.08
Williams %R
Neutral
Level
-70.4825
50-day SMA
Sell
Level
$31.11
MACD (12, 26)
Sell
Level
-1.97
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
18.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (31.5363)
Buy
CA Score
(Annual)
Level (1.7549)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-3.8761)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Stock Forecast FAQ
In the current month, SLP has received 6 Buy ratings 1 Hold ratings, and 0 Sell ratings. The SLP average analyst price target in the past 3 months is $49.40.
-
Where Will Simulations Plus Stock Be In 1 Year?
According to analysts, the consensus estimate is that Simulations Plus share price will rise to $49.40 per share over the next 12 months.
-
What Do Analysts Say About Simulations Plus?
Analysts are divided on their view about Simulations Plus share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Simulations Plus is a Sell and believe this share price will drop from its current level to $37.00.
-
What Is Simulations Plus's Price Target?
The price target for Simulations Plus over the next 1-year time period is forecast to be $49.40 according to 7 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is SLP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Simulations Plus is a Buy. 6 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SLP?
You can purchase shares of Simulations Plus via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Simulations Plus shares.
-
What Is The Simulations Plus Share Price Today?
Simulations Plus was last trading at $25.56 per share. This represents the most recent stock quote for Simulations Plus. Yesterday, Simulations Plus closed at $25.56 per share.
-
How To Buy Simulations Plus Stock Online?
In order to purchase Simulations Plus stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
